MENU
VCEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vericel (VCEL) Ownership - Who owns Vericel?

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets... Show more

Profile

Industry
Medical Specialties
Address
64 Sidney Street
Phone
+1 617 588-5555
Employees
314
Web
https://www.vcel.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.22B
P/E Ratio
221.55
Total Cash
116.21M
Projected Growth
N/A
Total Debt
98.85M
Revenue
237.22M
Risk (Beta)
1.28
Dividend Yield
N/A
Total Cash/Share
2.32
Total Debt/Equity
N/A
Revenue/Share
4.59 USD as % of share price

Fundamentals

VCEL
Capitalization
2.22B
P/E Ratio
221.55
Risk (Beta)
1.28
Dividend Yield
N/A
Total Cash
116M
Total Cash/Share
2.32
Total Debt
98.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.59%
Revenue
237M
ROE
N/A
Book Value
292M
P/B Ratio
7.61
Cash Flow
N/A
Earnings
0.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
685M
Current Ratio
4.23
Current Revenue Per Employee
211137.25
Dividends Per Share - Security
N/A
EBITDA
16.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
77.61
Revenue To Assets
2.64
Shares Held By Institutions
4.66B
Shares Outstanding - Current
50.1M
Total Liabilities
141M
Total Volume MTD
N/A
Value
-1
Gain YTD
-19.304
View a ticker or compare two or three
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of patient-specific expanded cellular therapies for use in the treatment of patients with diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
64 Sidney Street
Phone
+1 617 588-5555
Employees
314
Web
https://www.vcel.com